Academy Exchange

 View Only

  • 1.  Addressing the State Drug Utilzation Review Committee

    Posted 03-03-2020 08:51
    Edited by Robert Wallace 03-04-2020 06:42

    ------------------------------


  • 2.  RE: Addressing the State Drug Utilzation Review Committee

    Posted 03-04-2020 09:45
    Having done something similar in Connecticut in 2015, we became the first state to eliminate all restrictions on fibrosis scores and types of practitioners who can prescribe DAAs.  It opened access to all patients with any degree of HCV, and allowed any licensed prescriber to treat. I would suggest not only hitting on the cost effectiveness of treating patients by saving money down the line, which is true but not necessarily important to people controlling budgets, but also hit on the extrahepatic manifestations of HCV, like fatigue and how people who were previously unemployed may now return to the workforce.  You carry the energy of advocacy for doing the right thing and hopefully you will succeed.  Good luck.

    ------------------------------
    Gary Spinner
    South West Community Health Center
    New Haven CT
    ------------------------------

    Original Message


  • 3.  RE: Addressing the State Drug Utilzation Review Committee

    Posted 03-06-2020 20:00
    Thank you Gary,
    I appreciate the advice. I think the committee is close to accepting our advice about opening up the prescribing rights, and removing sobriety restrictions. I'm excited, they are making a step in the right direction
    Bob

                "Dr. Bob" Wallace
                    727-424-4101

    This email and any attachments are intended only for the individual or company to which it is addressed and may contain information which is privileged, confidential, and prohibited from disclosure or unauthorized use under applicable law. If you are not the intended recipient of this e-mail, you are hereby notified that any use, dissemination, or copying of this e-mail or the information contained in this email is strictly prohibited by the sender. If you have received this transmission in error, please return the material received to the sender and delete all copies from your system.




    Original Message


  • 4.  RE: Addressing the State Drug Utilzation Review Committee

    Posted 03-04-2020 15:07

    Thanks Bob!

     

     

     

     

     

    Jonathan S. Appelbaum, MD, FACP, AAHIVS

    Laurie L. Dozier, Jr., MD Education Director and Professor of Internal Medicine

    Chair, Department of Clinical Sciences

    Florida State University College of Medicine

    1115 West Call Street, Suite 3140-F

    Tallahassee, FL 32306-4300

    p. 850-645-1227    f. 850-644-0158

     

    FSU-TMH Internal Medicine Residency Clinic

    1300 Miccosukee Road

    Tallahassee, FL  32308

    Appointments:  850-431-7900   fax:  850-431-7990

     

    AAHIVS seal jpg

     

    "Please note: Florida has very broad public records laws.  Most written communications to or from state/university employees and students are public records and available to the public and media upon request.  Your e-mail communications may therefore be subject to disclosure."

     




    Original Message


Related Content